全文获取类型
收费全文 | 69387篇 |
免费 | 4820篇 |
国内免费 | 236篇 |
专业分类
耳鼻咽喉 | 774篇 |
儿科学 | 1936篇 |
妇产科学 | 1403篇 |
基础医学 | 8985篇 |
口腔科学 | 3406篇 |
临床医学 | 6533篇 |
内科学 | 14635篇 |
皮肤病学 | 1554篇 |
神经病学 | 5970篇 |
特种医学 | 1544篇 |
外国民族医学 | 3篇 |
外科学 | 9311篇 |
综合类 | 874篇 |
一般理论 | 29篇 |
预防医学 | 7973篇 |
眼科学 | 1111篇 |
药学 | 4705篇 |
中国医学 | 358篇 |
肿瘤学 | 3339篇 |
出版年
2023年 | 524篇 |
2022年 | 878篇 |
2021年 | 2336篇 |
2020年 | 1398篇 |
2019年 | 2081篇 |
2018年 | 2456篇 |
2017年 | 1655篇 |
2016年 | 1654篇 |
2015年 | 1991篇 |
2014年 | 2759篇 |
2013年 | 3496篇 |
2012年 | 5203篇 |
2011年 | 5558篇 |
2010年 | 2900篇 |
2009年 | 2489篇 |
2008年 | 4107篇 |
2007年 | 4238篇 |
2006年 | 3811篇 |
2005年 | 3577篇 |
2004年 | 3197篇 |
2003年 | 2891篇 |
2002年 | 2717篇 |
2001年 | 1156篇 |
2000年 | 1077篇 |
1999年 | 907篇 |
1998年 | 504篇 |
1997年 | 421篇 |
1996年 | 394篇 |
1995年 | 325篇 |
1994年 | 308篇 |
1993年 | 277篇 |
1992年 | 563篇 |
1991年 | 534篇 |
1990年 | 564篇 |
1989年 | 480篇 |
1988年 | 405篇 |
1987年 | 376篇 |
1986年 | 335篇 |
1985年 | 344篇 |
1984年 | 283篇 |
1983年 | 231篇 |
1982年 | 200篇 |
1981年 | 168篇 |
1980年 | 153篇 |
1979年 | 252篇 |
1978年 | 192篇 |
1976年 | 132篇 |
1974年 | 183篇 |
1973年 | 160篇 |
1969年 | 177篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献
6.
7.
8.
9.
10.
William R. C. Knight Cara R. Baker Nyree Griffin Wahyu Wulaningsih Mark Kelly Andrew R. Davies James A. Gossage 《British journal of cancer》2021,124(10):1653
Background A high Mandard score implies a non-response to chemotherapy in oesophageal adenocarcinoma. However, some patients exhibit tumour volume reduction and a nodal response despite a high score. This study examines survival and recurrence patterns in these patients.Methods Clinicopathological factors were analysed using multivariable Cox regression assessing time to death and recurrence. Computed tomography-estimated tumour volume change was examined in a subgroup of consecutive patients.Results Five hundred and fifty-five patients were included. Median survival was 55 months (Mandard 1–3) and 21 months (Mandard 4 and 5). In the Mandard 4 and 5 group (332 patients), comparison between complete nodal responders and persistent nodal disease showed improved survival (90 vs 18 months), recurrence rates (locoregional 14.75 vs 28.74%, systemic 24.59 vs 48.42%) and circumferential resection margin positivity (22.95 vs 68.11%). Complete nodal response independently predicted improved survival (hazard ratio 0.34 (0.16–0.74). Post-chemotherapy tumour volume reduction was greater in patients with a complete nodal response (−16.3 vs −7.7 cm3, p = 0.033) with no significant difference between Mandard groups.Conclusion Patients with a complete nodal response to chemotherapy have significantly improved outcomes despite a poor Mandard score. High Mandard score does not correspond with a non-response to chemotherapy in all cases and patients with nodal downstaging may still benefit from adjuvant chemotherapy.Subject terms: Oesophageal cancer, Surgical oncology 相似文献